Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 6/20 | 0.45 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.45 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.45 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | DGKA | P23743 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8160400 | 0.85 | PRKCA (0.54) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL9474382 | 0.85 | PRKCA (0.43) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL3453977 | 0.81 | MAPT (0.71) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL28225640 | 0.81 | MAPT (0.71) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL4597912 | 0.81 | PRKCA (0.49) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL402501 | 0.80 | MAPT (0.57) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL406117 | 0.80 | PRKCA (0.63) | PRKCAPRKCEPRKCQPRKCDLMNA | |
| SCHEMBL574940 | 0.78 | PRKCA (0.54) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| Levulinic Acid SCHEMBL408016 | 0.78 | LMNA (0.54) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL26008129 | 0.77 | PRKCA (0.49) | PRKCAPRKCEPRKCQPRKCDKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8906961-B2 | Glycerol levulinate ketals and their use in the manufacture of polyurethanes, and polyurethanes formed therefrom | SEGETIS, INC. (US) | 2014-12-09 | — | — | US | disclosed |
| US-20130303648-A1 | GLYCEROL LEVULINATE KETALS AND THEIR USE IN THE MANUFACTURE OF POLYURETHANES, AND POLYURETHANES FORMED THEREFROM | GFBIOCHEMICALS LIMITED (MT) | 2013-11-14 | — | — | US | disclosed |
| US-8492433-B2 | Glycerol levulinate ketals and their use in the manufacture of polyurethanes, and polyurethanes formed therefrom | SEGETIS, INC. (US) | 2013-07-23 | — | — | US | disclosed |
| EP-1954140-B1 | GLYCEROL LEVULINATE KETALS AND THEIR USE | SEGETIS INC (US) | 2013-05-29 | — | — | EP | disclosed |
| US-20120196947-A1 | GLYCEROL LEVULINATE KETALS AND THEIR USE IN THE MANUFACTURE OF POLYURETHANES, AND POLYURETHANES FORMED THEREFROM | SEGETIS, INC. (US) | 2012-08-02 | — | — | US | disclosed |
| US-8178701-B2 | Glycerol levulinate ketals and their use | SEGETIS, INC. (US) | 2012-05-15 | — | — | US | disclosed |
| US-20120021962-A1 | GLYCEROL LEVULINATE KETALS AND THEIR USE | SEGETIS, INC. (US) | 2012-01-26 | — | — | US | disclosed |
| US-8053468-B2 | Glycerol levulinate ketals and their use | SEGETIS, INC. (US) | 2011-11-08 | — | — | US | disclosed |
| US-20080242721-A1 | plasticizers; polylactones and polyurethanes prepared from them; substituted oxymethylene moiety attached to the dioxolane ring is predominantly in the cis configuration relative to the configuration of the side chain bearing the carboxyl group | AROMAGEN CORPORATION (US) | 2008-10-02 | — | — | US | disclosed |
| EP-1954140-A2 | GLYCEROL LEVULINATE KETALS AND THEIR USE | Aromagen Corporation (US) | 2008-08-13 | — | — | EP | disclosed |
| WO-2007062118-A2 | GLYCEROL LEVULINATE KETALS AND THEIR USE | AROMAGEN CORPORATION (US) | 2007-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242721-A1 | plasticizers; polylactones and polyurethanes prepared from them; substituted oxymethylene moiety attached to the dioxolane ring is predominantly in the cis configuration relative to the configuration of the side chain bearing the carboxyl group | GK, FTO, DGKK | PRKCA 62/4885PRKCE 124/4885PRKCQ 396/4885 |
| US-20120021962-A1 | GLYCEROL LEVULINATE KETALS AND THEIR USE | GK, GRIK5, KHK | PRKCA 351/4885PRKCE 280/4885PRKCQ 690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.